Cargando…
Spadin Selectively Antagonizes Arachidonic Acid Activation of TREK-1 Channels
TREK-1 channel activity is a critical regulator of neuronal, cardiac, and smooth muscle physiology and pathology. The antidepressant peptide, spadin, has been proposed to be a TREK-1-specific blocker. Here we sought to examine the mechanism of action underlying spadin inhibition of TREK-1 channels....
Autores principales: | Ma, Ruolin, Lewis, Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154116/ https://www.ncbi.nlm.nih.gov/pubmed/32317978 http://dx.doi.org/10.3389/fphar.2020.00434 |
Ejemplares similares
-
Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity
por: Djillani, Alaeddine, et al.
Publicado: (2017) -
The Involvement of Sortilin/NTSR3 in Depression as the Progenitor of Spadin and Its Role in the Membrane Expression of TREK-1
por: Mazella, Jean, et al.
Publicado: (2019) -
Spadin Modulates Astrocytic Passive Conductance via Inhibition of TWIK-1/TREK-1 Heterodimeric Channels
por: Bae, Yeonju, et al.
Publicado: (2020) -
Fluoxetine Protection in Decompression Sickness in Mice is Enhanced by Blocking TREK-1 Potassium Channel with the “spadin” Antidepressant
por: Vallée, Nicolas, et al.
Publicado: (2016) -
Spadin, a Sortilin-Derived Peptide, Targeting Rodent TREK-1 Channels: A New Concept in the Antidepressant Drug Design
por: Mazella, Jean, et al.
Publicado: (2010)